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Resolvin D1 (RvD1) and protectin D1 (Neuroprotectin D1, PD1/NPD1) are newly identified
anti-inflammatory lipid mediators biosynthesized from docosahexaenoic acid (DHA). In this
report, the spectra-structure correlations and fragmentation mechanisms were studied using
electrospray low-energy collision-induced dissociation tandem mass spectrometry (MS/MS)
for biogenic RvD1 and PD1, as well as mono-hydroxy-DHA and related hydroperoxy-DHA.
The loss of H2O and CO2 in the spectra indicates the number of functional group(s). Chain-cut
ions are the signature of the positions and numbers of functional groups and double bonds.
The observed chain-cut ion is equivalent to a hypothetical homolytic-segment (cc, cm, mc, or
mm) with addition or extraction of up to 2 protons (H). The -cleavage ions are equivalent to:
[cc  H], with H from the hydroxyl through a -ene or -ene rearrangement; [cm  2H], with
2H from hydroxyls of PD1 through a -ene rearrangement, or 1H from the hydroxyl and the
other H from the -carbon of mono-HDHA through an -H--ene rearrangement; [mc  H],
with H from hydroxyl through a -ene or -ene rearrangement, or from the -carbon through
an -H--ene rearrangement; or [mm] through charge-direct fragmentations. The -ene or
-ene facilitates the H shift to  position and -cleavage. Deuterium labeling confirmed the
assignment of MS/MS ions and the fragmentation mechanisms. Based on the MS/MS spectra
and fragmentation mechanisms, we identified RvD1, PD1, and mono-hydroxy-DHA products
in human neutrophils and blood, trout head-kidney, and stroke-injury murine brain-
tissue. (J Am Soc Mass Spectrom 2007, 18, 128–144) © 2007 American Society for Mass
SpectrometryNumerous reports demonstrate the beneficial ef-fects of fish oil on human diseases such as arthri-tis, Alzheimer’s disease, lung fibrosis, and in-
flammatory bowel diseases [1–3]. As an essential -3
polyunsaturated fatty acid, docosahexaenoic acid (DHA)
is a major component of fish oil [4]. Novel bioactive
oxygenated DHA products biosynthesized in resolving
inflammatory exudates and tissues were recently identi-
fied, and their structures and bioactions were elucidated
[5– 8]. They were named as the D series of resolvins
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doi:10.1016/j.jasms.2006.09.002 (resolution phase interaction products) and protectins
(protecting brain and other organs against inflammatory
diseases) because their biosynthetic pathways display
potent anti-inflammatory and immunoregulatory proper-
ties (Scheme 1)[5–9]. As illustrated in Scheme 1, DHA is
initially converted to 17S-hydroperoxy-DHA (HpDHA),
then further enzymatically transferred to resolvin
D1(RvD1) and protectin D1 (neuroprotectin D1, PD1/
NPD1) via epoxide intermediates. With aspirin treatment,
the aspirin-acetylated cyclooxygenase type II (COX-2)
converts DHA into 17R-HpDHA, which is further con-
verted to 17R-RvD1 and 17R-PD1 [5].
To obtain the temporal and spatial profiles and
regulation of biosynthesis of RvD1 and PD1 as well as
other DHA products during physiopathological pro-
cesses, their identification needs to be accurate, sensi-
tive, and fast. One suitable approach is liquid chroma-
tography coupled to an ultraviolet spectrometer and a
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129J Am Soc Mass Spectrom 2007, 18, 128–144 MS/MS OF DHA PRODUCTS: RESOLVIN/PROTECTIN D1low collision-energy tandem mass spectrometer (LC-
UV-MS/MS) with atmospheric pressure ionization,
specifically electrospray ionization (ESI) [5– 8]; this is
used on full product ion scan bases for structure eluci-
dation and identification of resolvins and protectins at
low nanogram levels [5– 8]. Authentic standards of
resolvins and protectin D1 prepared via total organic
synthesis are used for confirmation during the identifi-
cation. The low levels (under a few nanograms/sample)
of these mediators present in vivo make other instru-
mentation, such as nuclear magnetic resonance or opti-
cal spectrometers, inappropriate for the analysis. In
comparison, different types of mass spectrometry were
used in the earlier studies of DHA-derived products.
These included gas chromatography-MS with electron-
impact ionization used by Van Rollins and Murphy and
coworkers to analyze the structures of mono-hydroxy-
DHA products after silanization and methylation [9].
Kim and Salem conducted preparation and structure
analysis of HDHAs and HpDHAs using LC-positive ion
thermospray MS/MS [10]. They also developed an
analytical method and conducted stereochemistry stud-
ies of all the HDHAs produced by human platelets and
rat brain homogenates using chiral LC-thermos-
pray-MS and GC/MS (electron-impact ionization) [11].
Low-energy ionization primarily generates molecu-
lar (or pseudo-molecular) ions for collision-induced
dissociation (CID) MS/MS analysis, through which the
MS/MS spectra obtained are used widely to identify
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Scheme 1. Biosynthetic pathways for Resolvin D1 (RvD1) and
Protectin D1 (PD1).and elucidate the structures of lipid mediators derivedfrom polyunsaturated fatty acids [12–20]. The low-
energy CID of eicosanoids includes charge-remote and
charge-directed fragmentations [12, 21], many of which
occur through “-hydroxy--ene like rearrangement”
as referred to by Murphy, i.e., -cleavage of the
carbonOcarbon bond ( position to hydroxy group),
facilitated by a double bond (ene) in the  position [22].
For polyunsaturated fatty acids and their derivatives,
ions formed in low-energy CID MS/MS via the loss of
only H2O and CO2 are usually much more abundant
than ions formed through cleavage of the carbon chain.
In this report, the former are called “peripheral-cut
ions” and the latter are called “chain-cut ions.”
Peripheral-cut ions provide information about the num-
ber of hydroxys and carboxylates in a compound; chain-
cut ions are the signatures for the positions of hydroxys
and double bonds. The ions formed via a combination of
chain-cut and peripheral-cut processes are called “chain-
plus-peripheral-cut” ions [23]. The structure of a com-
pound is deduced from the integration of the structures
assigned to its MS/MS ions. Thus, the fragmentation
mechanisms for the formation of MS/MS ions are very
important for the identification using the MS/MS ions of
a novel and/or known molecular structure. These mech-
anisms form the basis for lipidomic databases, which
consist of lipid mass spectra and other analytical data, and
search algorithms [23].
Here, we report the analysis of resolvin D1 and
protectin D1, as well as other DHA-derived products
without derivatization, using low-collision-energy tan-
dem mass spectra acquired on anions generated from
electrospray ionization of molecules eluted from LC.
For structure elucidation and identification, the ion
structures and MS/MS fragmentation mechanisms are
proposed and confirmed via deuterium-labeled isoto-
pomers of these compounds. RvD1 and PD1, as well as
mono-hydroxy-DHA products, were found to be gen-
erated by human neutrophils, whole blood [6], trout
head-kidney [25], and stroke-injury murine brain tis-
sues [7], using this LC-UV-MS/MS approach.
Experimental
Instrumentation
The MS/MS spectrum was acquired on each chromato-
graphic peak eluted from a column of a LC-UV-MS/MS
system. This system includes a HPLC (P4000) coupled
to a photo-diode-array UV detector and an ion trap
(LCQ) MS/MS (Thermoelectron, San Jose, CA). Ap-
proximately 10 ng of each authentic standard were
injected individually into the column (LUNA C18-2 150
mm 2 mm 5 m, Phenomenex, Torrance, CA), which
was eluted at 0.2 ml/min and 23 °C. The mobile phase
flowed as C (water:methanol:acetic acid  65%:35%:
0.01%) from 0 to 50 min; ramped to 100% methanol
from 50.1 to 110 mins; maintained as 100% methanol for
10 mins, then back to C. The UV detector scanned from
200 to 400 nm, providing additional spectral confirma-
130 HONG ET AL. J Am Soc Mass Spectrom 2007, 18, 128–144tion to ensure the purity of the authentic standards. For
RvD1, PD1, mono-hydroxy-DHAs (HDHAs), and Hp-
DHA, the maximum UV absorption wavelengths are
301 nm, 270 nm, and 235 nm, respectively. Conditions
for the mass spectrometer are: electrospray voltage, 4.3
kV; heating capillary, 39 V; tube lens offset, 60 V;
sheath N2 gas, 1.2 L/min; and auxiliary N2 gas, 0.045
L/min; collision energy was 35 to 45% (a relative
collision energy of 0 to 100% corresponds to a high-
frequency alternating voltage for resonance excitation
from 0 to 5 V maximum); helium gas, 0.1 Pa as a
collision gas; and scan range, m/z 95 to 390 [23].
Materials and Sample Preparation
Biogenic syntheses of RvD1, 17S-HDHA, and 17-HpDHA
were conducted via incubation of DHA (Cayman Chem-
ical, Ann Arbor, MI) [5, 6, 24] with isolated enzyme(s), i.e.,
soybean 15-lipoxygenase and/or potato 5-lipoxygenase
(Sigma Co., St. Louis, MO). Following the same proce-
dures but replacing DHAwith d5-DHA (21,21,22,22,22-d5-
DHA) (Cayman Chemical), we prepared d5-RvD1, d5-
PD1, d5-17S-HDHA, and d5-17-HpDHA, and acquired
their spectra and chromatograms on LC-UV-MS/MS. The
structures of biogenically synthesized RvD1 and PD1
were further confirmed via matching the spectra of
MS/MS and UV (coupled to a LC), GC/MS, and chro-
matographic retention times of RvD1 and PD1, which
were prepared by total organic synthesis [24, 26]. HDHAs
were purchased from Cayman Chemical. All other re-
agents were from available commercial sources at the
highest grade.
Some of the deuterium-labeled compounds were ob-
tained via deuterium-exchange of labile hydrogens in the
hydroxy(s) and carboxylate, which include O,O,O,O-d4-
RvD1, O,O,O,21,21,22,22,22-d8-PD1 (from deuterium ex-
change of labile hydrogens in the two hydroxys and one
carboxylate of d5-PD1), O,O,O-d3-PD1, and O,O-d2-
HDHAs. The deuterium-exchange was achieved when
the samples were analyzed on LC-UV-MS/MS using the
same gradient as described above except substituting
MeOD, D2O, and d-acetic acid for methanol, water, and
acetic acid, respectively.
Samples of human whole blood (venous) and PMN
were obtained and prepared as described elsewhere [6].
Stroke-injury murine brain tissues were provided by Pro-
fessor N. Bazan’s group at Louisiana State University
Health Sciences Center. The surgery procedures and sam-
ple preparation have also been described [7]. Samples of
trout brain and head-kidney were prepared as in [25]. All
samples were added with two volumes of cold methanol
[6]. Briefly, this procedure is tailored as follows. The
samples were centrifuged (3000 rpm, 4 °C, 15 min) to
remove cellular and protein materials. After the superna-
tants were decanted, theywere dilutedwith 10 volumes of
water purified with the Milli-Q System (Millipore, Bil-
lerica, MA). The pH was adjusted to 3.5 with 1 M HCl for
C18 solid-phase extraction (SPE). After a wash with 15 ml
of H2O and then 8 ml of hexane, the SPE cartridges (C18,3 ml, Waters, Millford, MA) were eluted with 8 ml of
methyl formate, and the effluent was reconstituted into
methanol for lipidomic analysis using LC-UV-MS/MS.
Nomenclature
To illustrate the interpretation of MS/MS ions generated
from RvD1, PD1/NPD1, and other related DHA-derived
products, we use the nomenclature recently proposed [23]
to name the specific “segments”, which are fragments
formed through hypothetic homolytic cleavages without
hydrogen or group migration. This is depicted in Scheme
2 using RvD1 and PD1 structures. A number is used to
designate the position of a hydroxy or another functional
group on the carbon-chain where the cleavage occurs. The
letter immediately following the number indicates the side
of the functional group on which the cleavage occurs: “c”
is for cleavage on the carboxyl side of the functional group
and “m” is for cleavage on the methyl side of the func-
tional group. Each cleavage can directly generate two
segments. The second letter indicates the side of the
cleavage onwhich the segment forms: “c” is for a segment
formed on the carboxyl side of the cleavage and “m” is for
a segment formed on the methyl side of the cleavage.
Segments formed through -cleavage or -cleavage along
the functional group are named by adding  or  between
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Scheme 2. Naming hypothetic-homolytic-segments of lipid me-
diators with RvD1 and PD1/NPD1 as an example.the two “c”/“m” letters [23].
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The electrospray ionization in negative mode generated
primarily deprotonated molecular ions [M  H or D]
from resolvin D1 (Figure 1), protectin D1, other related
DHA-derived compounds, and their deuterium isoto-
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Figure 1. Low-energy MS/MS spectra acquire
anion [M  H or D] from the LC peak of resolv
and 21,21,22,22,22-d5-RvD1were obtained from is
exchange, as well as from human PMN, as detail
structure and CID fragmentation.pomers eluted from the LC column. In MS/MS exper-iments, [M  H] ions were selected and fragmented
via CID. Cleavage on the carbon chain was frequently
observed on the  locations toward hydroxy and hy-
droperoxy. This is similar to the CID fragmentation of
derivatives from arachidonic acid and eicosapentaenoic
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132 HONG ET AL. J Am Soc Mass Spectrom 2007, 18, 128–144RvD1, O,O,O,O-d4-RvD1, and 21,21,22,22,22-d5-
RvD1 (Figure 1 and Scheme 3).
RvD1 is 7S,8R,17S-trihydroxy-docosa-4Z,9E,11E,13Z,15E,
19Z-hexaenoic acid, which has three hydroxy groups and
six double bonds, four of which are conjugated and
bracketed by the 8-hydroxy and 17-hydroxy (see inset of
Figure 1). The low collision-energy MS/MS spectrum of
the LC peak of the RvD1 shows peripheral-cut ions at m/z
357 [M  H  H2O] (relative intensity is 47%), 339 [M 
H 2H2O] (32%), 331 [MH CO2] (52%), 313 [MH
 H2O-CO2] (10%), and 295 [M  H  2H2O-CO2] (26%)
(Figure 1). The assignment of these ions is consistent with
O,O,O,O-d4-RvD1 (d4-RvD1), ions: 360 [M  D  H2O]
(27%), 341 [M  D  H2O-HDO] (14%), 334 [M  D 
CO2] (22%), 316 [MDH2O-CO2] (14%), and 297 [M
D  HDO-H2O-CO2] (12%); 21,21,22,22,22-d5-RvD1 (d5-
RvD1) ions: 362 [M  H  H2O] (100%), 344 [M  H 
Scheme 3. Fragmentation mechanisms f2H2O] (46%), 336 [M  H  CO2] (27%), 318 [M  H H2O-CO2] (25%), and 300 [M  H  2H2O-CO2] (24%);
and d4-RvD1 also possesses ions 359 [M  D  HDO]
(14%), 342 [M  D  2H2O] (4%), 315 [M  D 
HDO-CO2] (8%), and 298 [M  D  2H2O-CO2] (8%).
These peripheral-cut ions support the existence of the
carboxyl group (for CO2 loss) and hydroxy groups
(for H2O loss) in RvD1. However, these ions do not
provide the specific information or clues for the
positions of the hydroxy(s) and double bonds. The
loss of H2O from d4-RvD1, whose hydroxy hydrogens
were completely deuterated, indicates that the deu-
teroxy deuterium is exchanged with the carbon-
chain-bonded hydrogen. The chain-cut MS/MS ions
of RvD1 are as follows: some of them further transfer
to chain-plus-peripheral-cut ions via loss of water or
CO2. Chain-cut and chain-plus-peripheral-cut ions
provide the signatures for the positions of functional
D1/d4-RvD1 ([M-H/D]m/z 375/378).groups and double bonds.
133J Am Soc Mass Spectrom 2007, 18, 128–144 MS/MS OF DHA PRODUCTS: RESOLVIN/PROTECTIN D1The ion m/z 141 (44%) of RvD1 is equal to segment 7
mc minus the 7-hydroxy proton (H from 7-OH or 7-OH
H), namely [7 mcH from 7-OH] corresponding to the
following mechanism (Scheme 3). When the 7-OH H is
extracted, through a transit six-membered ring, to C10
by the double bond C9,10, which is at  position to
7-OH, 7-OH converts to a carbonyl group, the allylic
single bond C7,8 at  position to 7-OH cleaves, and the
C8,9 double bond forms, yielding ion m/z 141 and an
enol. We refer to such process having -ene facilitated
-OH H migration and -cleavage as a “-ene rear-
rangement.” The mechanism was confirmed by ion m/z
141 as [7 mc deuteron from 7-deuteroxy] (i.e., [7 mc
D from 7-OD]) from d4-RvD1 and as [7 mc  H from
7-OH] from d5-RvD1.
In competition with the formation of ion m/z 141,
7-OH H shifts to the carboxyl anion internally, forming
7-alkoxide anion S3a. The negative charge of S3a directs
the cleavage of C7,8 allylic single bond at  position,
resulting in ion m/z 233 (100%) [corresponding to ions
m/z 235 (100%) for d4-RvD1 and 238 (26%) for d5-RvD1]
(Figure 1), which is equivalent to segment [7 mm].
Additionally, the deuterium labeling on C21 and C22 of
d5-RvD1 changed the base-peak from ion m/z 233 of
RvD1 or m/z 235 (equivalent to [7 mm]) of d4-RvD1 to
ion m/z 362 [M  H  H2O].
Ion m/z 189 is equal to [8 mm  H] for RvD1, which
is equivalent to ion m/z 190 [8 mm  H] for d4-RvD1.
Their formation corresponds to the following mecha-
nism. Initially, H from C17 of the parent ion is extracted
to C9 by C9,10 double bond at  position to 8-OH and
the conjugated tetraene 9,11,13,15 converts to
10,12,14,16 in S3b. When 17-OH H (or D 17-OD D)
moves to C10, this tetraenol S3b changes to tetraenone
S3c; meanwhile, the 8-OH H (or 8-OD D for d4-RvD1)
migrates to the carboxylate anion, resulting in the
8-alkoxide anion S3c. Then the negative charge of the
S3c directs the breakage of the C9,10 allylic single bond
at the  position to the 8-alkoxide group, yielding ion
m/z 189 (14%) from RvD1, m/z 190 (6%) from d4-RvD1,
and m/z 194 (7%) from d5-RvD1. We refer to such
process with -cleavage facilitated by -OH and -ene
as a “-cut--ene rearrangement.”
Ion m/z 277 (75%) of RvD1 and ion m/z 280 (32%) of
d4-RvD1 are equivalent to [17 cc  H from 17-OH] and
[17 cc  D from 17-OD], respectively. They correspond
to the -cleavage of the C16,17 bond of their parent
ions, of which the  double bond C15,16 facilitates the
cleavage. This is a typical -hydroxy--ene-like rear-
rangement (abbreviated as -ene rearrangement) [22].
When the conjugated triene 11,13,15 of the parent ion
forms a six-membered ring in S3d, the  double bond
C15,16 shifts to  position, forming a C14,15 double
bond, and the vinyl single bond C16,17 becomes the
allylic single bond C16,17 in S3d. Then the 17-OH H (or
7-OD D in d4-RvD1) shifts to C14 of the  double bond
C14,15, a 17-carbonyl group forms, and the C16,17
allylic single bond cleaves, producing ion m/z 277 of
RvD1 and d5-RvD1[or 280 of d4-RvD1]. Thus, this -enerearrangement includes conversion of -ene to -ene
and vinyl single bond to  allylic single bond, and
subsequently the -ene rearrangement, similar to the
case of the ion m/z 141 from RvD1 discussed above.
When the C16-proton (H) in S3d shifts to C20,
instead of the shift of H from 17-OH to C20 (which
would have generated ion m/z 307 for d5-RvD1), the
C17,18 allylic single bond fragments, yielding ion m/z
305 (11%, equivalent to [17 mc  H from C16]) from
RvD1. This mechanism is confirmed by ionm/z 308 (5%)
from d4-RvD1 (Scheme 3) and ion m/z 305 (6%) from
d5-RvD1. We refer to this process as “-H--ene
rearrangement.”
The 17-OH in S3d is competitively deprotonated
internally by its carboxyl anion to form a C17-alkoxide
anion, of which the negative charge directs the breakage
of C16,17 allylic single bond, generating ion m/z 277;
similar to that discussed for S3d above, a charge-remote
process for this alkoxide anion, also involving the
migration of C16-H to C20, cleaves allylic single bond
C17,18 and generates ion m/z 305 [12] (Scheme 3). This
is also an -H--ene rearrangement. The -H is less
active than H from -OH because the COH bond is
much less polarized than the OOH bond; thus the
abundance of ion m/z 277 is higher than that of ion m/z
305 for RvD1 and d5-RvD1. The same pattern is ob-
served: ion m/z 280 is more abundant than ion m/z 308
for d4-RvD1, and ion m/z 277 is more abundant than ion
m/z 305 for d5 RvD1.
The loss of water and/or CO2 generated ions 259
[277H2O] for RvD1(15%) and d5-RvD1(16%), 241 [277
 2H2O] for RvD1 (11%) and d5-RvD1 (6%), 215 [277 
H2O-CO2] for RvD1 (32%) and d5-RvD1 (15%), and 217
[280  HDO-CO2] (7%) for d4-RvD1, which further
confirmed the structure assignment of ion m/z 277.
Using this LC-UV-MS/MS analysis, RvD1 was found to
be biosynthesized by human neutrophils. The MS/MS
spectrum of a chromatographic peak acquired from the
samples of human neutrophils matches the spectrum of
standard RvD1 (bottom panel, Figure 1), as do the UV
spectrum and chromatographic retention time (data not
shown).
PD1, O,O,O-d3-PD1, 21,21,22,22,22-d5-PD1,
and O,O,O,21,21,22,22,22-d8-PD1 (Figure 2
and Scheme 4).
Among the six double bonds of PD1 (protectin
D1/neuroprotectins D1: 10R,17S-dihydroxy-docosa-
4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid), three are conju-
gated between 10-OH and 17-OH (see Figure 2 inset).
Negative electrospray ionization generated ion m/z 359,
a deprotonated molecular ion [MH], from PD1. The
MS/MS spectrum at m/z 359 of PD1 from trout head-
kidney matches to that acquired from synthetic PD1
(see Figure 1 of reference [25]). There are peripheral-cut
ions atm/z of 341 [MHH2O] (100%), 323 [MH
2H2O] (20%), 315 [M  H  CO2] (29%), 297 [M  H 
frag
134 HONG ET AL. J Am Soc Mass Spectrom 2007, 18, 128–144H2O-CO2] (39%), and 279 [M  H  2H2O-CO2] (7%),
consistent with the PD1 structure of one carboxylic
group and two hydroxy groups. These ions are equiv-
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[MHH2O] (100%), 328 [MH 2H2O] (13%), 320
[M  H  CO2] (23%), 302 [M  H  H2O-CO2] (27%),
and 284 [M  H  2H2O-CO2] (6%), respectively; and
along with ions from MS/MS of d8-PD1
(O,O,O,21,21,22,22,22-d8-PD1) at m/z 348 [M  D 
H2O] (100%), 329 [M  D  H2O-HDO] (30%), 322 [M
 D  CO2] (41%), 304 [M  D  H2O-CO2] (35%), and
284 [M  D  2HDO  CO2] (3%), respectively. It is
interesting that some of the water loss was as H2O
rather than HDO. Loss of HDO is expected for d3-PD1
because D has replaced every hydroxy H. D in the
deuteroxy group exchanged with the hydrogen on the
carbon chain when the [M  D] ion of d3-PD1 was
selected and activated for the MS/MS fragmentation in
the ion trap, similar to d4-RvD1 (see above). The
MS/MS chain-cut ions and the formation mechanisms
are shown in Figure 2 and Scheme 4. Those ions formed
via loss of H2O from d3-PD1 also manifest the exchange
of deuteroxy deuterium with carbon-chain-bonded
hydrogen.
The MS/MS ion m/z 153 of PD1 is consistent with the
fragmentation mechanism of a -ene rearrangement:
when the 10-OH H shifts to the C7 at  double bond
C7,8 through a 6-membered ring, a carbonyl group
forms (in S4a) and the C9,10 allylic single bond, at
-position to 10-OH, cleaves, yielding the ion at m/z 153
in MS/MS of PD1 (11%) and d5-PD1 (7%). The equiva-
lent ion is at m/z 154 for d3-PD1 (7%) and d8-PD1 (5%).
Ions m/z 153 and 154 are equal to [10 cc  H from
10-OH] (for PD1 and d5-PD1) and [10 cc  D from
10-OD] (for O,O,O-d3-PD1 and d8-PD1), respectively. If
Scheme 4. Fragmentation mechanismsadditionally the 17-OH H or 17-OD D shifts to thecarboxyl anion, it yields the neutral molecule S4b and
ion m/z 205, equal to [10 cm  2H from hydroxys] for
PD1 (7%) or [10 cm  2D from deuteroxys] for d3-PD1
(7%). Its equivalent ion is at m/z 210 (6%) for d5-PD1.
The assignment of ions m/z 205 and 210 is consistent
with ion 187 [205  H2O] (4%) of PD1.
Ion m/z 181 is equal to [10 mc  H from OH] for PD1
(5%) and d5-PD1 (10%), or to [10 mc  D from OD] for
d8-PD1 (29%) and d3-PD1 (10%). The corresponding
fragmentation mechanism is a charge-remote -ene
rearrangement with -OH as 10-OH and -ene as
C11,12 double bond of the parent ion: the conjugated
triene 11,13,15 in PD1 forms a six-membered ring in
intermediate S4c via the Diels-Alder process, changing
the vinyl single bond C10,11 at position to an allylic
single bond (Scheme 4); then the H from 10-OH moves
to C13 on the newly formed -ene (at C12,13), the allylic
single bond C10,11 breaks, and 10-carbony forms, gen-
erating S4d and ionm/z 181. Additional evidence for the
composition of ion m/z 181 is ion m/z 163 [181  H2O]
(5%) in the MS/MS spectrum of PD1 (Figure 2,
Scheme 4).
Ion m/z 261 (20%) in the MS/MS spectra of PD1 is
equivalent to [17 cc  H from 17-OH] (Scheme 4),
generated through a -ene rearrangement analogous to
the formation mechanism for ion m/z 277 from RvD1
(Figure 1 and Scheme 3). When 17-OH H shifts to C14 in
S4c, the allylic single bond C16,17 breaks, resulting in a
carbonyl group in the neutral loss hexen-3-al and ion
m/z 261. This is verified by ion m/z 263 from d3-PD1
(37%) and d8-PD1 (15%), equal to [17 cc  D from
17-OD]; and ionm/z 261 (23%) from d5-PD1, equal to [17
D1/d3-PD1 ([M-H/D]m/z 359/361).cc  H from 17-OH]. This fragmentation mechanism is
136 HONG ET AL. J Am Soc Mass Spectrom 2007, 18, 128–144further confirmed by ions m/z 217 [261  CO2] and 199
[261  H2O-CO2] from both PD1 (9%, 5%) and d5-PD1
(7%, 5%), as well as by ions m/z 219 [263  CO2] (12%)
and 200 [263  HDO  CO2] (9%) from d3-PD1. Ions
m/z 219 [263  CO2] and 201 [263  H2O-CO2] from
d8-PD1 (10%, 11%) are also consistent with this
mechanism.
The formation of ion m/z 289 of PD1 corresponds to
the -H--ene rearrangement, which is analogous to
that for ion m/z 305 from RvD1 (Figure 1 and Scheme
3), with the shift of C16 H instead of 17-OH H, where
-OH is 17-OH, and -ene is C19,20 double bond.
When C16 H shifts to C20 in S4c, the allylic single
bond C17,18 cleaves, yielding a pentaene (neutral
loss) and ion m/z 289 (5%) with a 17-enol and a
six-membered ring (Figure 2, Scheme 4 ). This frag-
mentation process was confirmed by ion m/z 289 from
d5-PD1 (4%) and ion m/z 291 from d3-PD1 (9%) and
d8 -PD1 (16%) (Figure 2). Therefore ions m/z 289 and
291 are equal to [17 mc  H from C16] of PD1 and
d3 -PD1, respectively (Figure 2 and Scheme 4 ). This
process was consistent with the chain-plus-peripheral-
cut ions formed from m/z 289 and 291 via loss of
water or/and CO2: 271 [289  H2O], 245 [289  CO2],
and 227 [289  H2O-CO2] from PD1 (4%, 10%, 4%)
and d5-PD1 (5%, 18%, 4%); 272 [291  HDO] (5%), 247
[291  CO2] (23%), and 228 [291  HDO  CO2] (4%)
Table 1. Chain-cut ions and fragmentation mechanisms for low
carboxylate anion [M - H or D]- from the LC peak of a mono-HD
-HDHA
ion
m/z Algorithm H is from
Fr
re
cca 20- 285 20ccH 20-OH -
17- 245 17ccH 17-OH -
16- 233 16ccH 16-OH -
14- 205 14ccH 14-OH -
13- 193 13ccH 13-OH -
11- 165 11ccH 11-OH -
10- 153 10ccH 10-OH -
cm 11- 177 11cm-2H 11-OH,12C -
8- 217 8cm-2H 8-OH,9C -
mc 17- 273 17mc-H 16C -
16- 261 16mc-H 15C -
14- 233 14mc-H 13C -
13- 221 13mc-H 13-OH -
11- 193 11mc-H 11-OH -
10- 181 10mc-H 10-OH -
8- 153 8mc-H 8-OH -
7- 141 7mc-H 7-OH -
4- 101 4mc-H 4-OH -
mm 11- 149 11mm n.a.b ch
8- 189 8mm n.a. ch
7- 201 7mm n.a. ch
ahypothetical homolytic-segment;
bnot applicable.from d3-PD1; 272 [291  HDO] (29%), 247 [291 CO2] (47%), and 229 [291  H2O-CO2] (15%) from
d8-PD1.
The stereoisomers of PD1 were obtained through
total organic synthesis [26], and are indistinguishable
based only on their MS/MS spectra [24] and data not
shown. However, most can be separated via reversed-
phase LC [24]. Their bioactivities were found to depend
on their stereo-structures [24].
HDHAs and O,O-d2-HDHAs (Table 1,
Supplemental Figure 1 (see electronic version
of this article), and Scheme 5).
The hydroxy of each mono-hydroxy docosahexaenoic
acid (HDHA) reported here is at the  position relative
to its conjugated-diene. The electrospray-generated mo-
lecular ion for each HDHA eluted from the LC column
is at m/z 343 [M  H]. The peripheral-cut ions from
low-energy MS/MS at m/z 343, generated via neutral
losses, are at m/z 325 [M  H  H2O], 299 [M  H 
CO2], and 281 [M  H  H2O-CO2]. These ions are
consistent with ions generated from MS/MS at m/z 344
[M  D], for any labile-hydrogen-deuterated HDHA
(O,O-d2-HDHA or d2-HDHA), namely, m/z 325 [M  D
 HDO] or 326 [M  D  H2O], 300 [M  D  CO2],
and 281 [M  D  HDO-CO2] and 282 [M  D 
gy MS/MS spectra obtained via CID of electrospray-generated
or O,O-d2-mono-HDHA
entation
gement
Confirmation by deuterium-labeling
labeled-
HDHA
ion
m/z Algorithm D/H is from
d2-20- 286 20ccD 20-OD
d2-17- 246 17ccD 17-OD
d2-16- 234 16ccD 16-OD
d2-14- 206 14ccD 14-OD
d2-13- 194 13ccD 13-OD
d2-11- 166 11ccD 11-OD
d2-10- 154 10ccD 10-OD
ne d2-11- 177 11cm-D-H 11-OD, H
from 12C
ne d2-8- 217 8cm-D-H 8-OD, H
from 9C
ne d2-17- 274 17mc-H H from 16C
ne d2-16- 262 16mc-H H from 15C
ne d2-14- 234 14mc-H H from 13C
d2-13- 221 13mc-D 13-OD
d2-11- 193 11mc-D 11-OD
d2-10- 181 10mc-D 10-OD
d2-8- 153 8mc-D 8-OD
d2-7- 141 7mc-D 7-OD
d2-4- 101 4mc-D 4-OD
-direct d2-11- 149 11mm n.a.
-direct d2-8- 189 8mm n.a.
-direct d2-7- 201 7mm n.a.ener
HA
agm
arran
ene
ene
ene
ene
ene
ene
ene
H--e
H--e
H--e
H--e
H--e
ene
ene
ene
ene
ene
ene
arge
arge
argeH2O-CO2], respectively, where ions m/z 326 [M  D 
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138 HONG ET AL. J Am Soc Mass Spectrom 2007, 18, 128–144H2O] and 282 [M  D  H2O-CO2] demonstrated that
the deuteroxy D was exchanged with carbon-chain
hydrogens before the water loss in MS/MS processes.
The LC-UV-MS/MS analysis also showed that the LC
peak of each HDHA has an asymmetric band at max
233–236 nm in the UV spectrum (data not shown),
indicating the presence of a conjugated diene in each
HDHA.
20-HDHA and O,O-d2 -20-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). The first HDHA eluted from
the LC column is 20-HDHA (20-hydroxy-4Z,7Z,10Z,
13Z,16Z,18E-docosahexaenoic acid). MS/MS ion m/z
285 (35%) or 286 (50%) results from segment 20 cc,
equivalent to [20 cc  H from 20-OH from 20-HDHA]
or [20 cc  D from 20-OD of O,O-d2-20-HDHA], via a
-ene rearrangement with cleavage of the C19,20
bond. Before the cleavage of the C19,20 bond, the C15
H shifts to C19, and conjugated double bond 16,18
changes to 15,17. Then the 20-OH H migrates to C17
(S5a) and the newly-formed allylic single bond
C19,20 cleaves.
17-HDHA and O,O-d2-17-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). Ion m/z 245 (41%) is equivalent
to 17 cc plus H from 17-OH of 17-HDHA (17-hydroxy-
4Z,7Z,10Z,15E,19Z-docosahexaenoic acid). This is fur-
ther confirmed by ion m/z 246 [17 cc  D from 17-OD]
(60%) from O,O-d2-17-HDHA (Table 1, Supplemental
Figure 1). The migration of C12-H to C16 leads to the
transfer of conjugated double bonds 13,15 to 12,14 in
S5b. A 17-alkoxide anion is generated when 17-OH H
(or 17-OD D) shifts to the carboxyl in S5b. The negative
charge of the 17-alkoxide anion directs the cleavage of
the C16,17 bond, resulting in ion m/z 245 of 17-HDHA
(246 of d2-17-HDHA). This ion also forms through a
charge-remote -ene rearrangement similar to that for
ion m/z 277 from RvD1 (Figure 1 and Scheme 3) and ion
m/z 153 from PD1 (Figure 2, Scheme 4): the 17-alkoxide
in S5b is in 17-OH form, of which the H shifts to C14,
then the double bond C14,15 shifts to C15,16 and the
allylic single bond C16,17 cleaves, resulting in ion m/z
245.
An -H--ene rearrangement, similar to that for ion
m/z 305 from RvD1 (Figure 1 and Scheme 3) and ion m/z
289 from PD1 (Figure 2, Scheme 4), also occurs for
17-HDHA: when C16-H shifts to C20 through a six-
membered ring in S5b, of which the 17-alkoxide anion is
also in 17-OH form, the C17,18 bond cleaves, yielding
ion m/z 273 (54%) equivalent to [17 mc  H from C16].
This ion is equivalent to ion m/z 274 [17 mc  H
from C16] (50%) from O,O-d2-17-HDHA. Chain-plus-
peripheral ions, resulting from the above ions via loss of
H2O and/or CO2, are 201 [245 CO2] (12%), 229 [273
CO2] (19%), and 255 [273  H2O] (13%) of 17-HDHA;
and 202 [246  CO2] (13%), 230 [274  CO2] (21%), and
256 [274  H2O] (10%) of O,O-d2-17-HDHA. The ap-
pearance of these chain-plus-peripheral ions furtherconfirms the presence of a carboxyl and/or hydroxy in
the originating ions.
16-HDHA and O,O-d2-16-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). The ion m/z 233 (85%) or 234
(100%) in the MS/MS spectrum of 16-HDHA (16-
hydroxy-4Z,7Z,10Z,13Z,17E,19Z-docosahexaenoic acid)
or O,O-d2-16-HDHA is equivalent to [16 cc  H from
16-OH of 16-HDHA] or [16 cc  D from 16-OD of
O,O-d2-16-HDHA], respectively. Furthermore, ion m/z
261 (60%) or 262 (35%) is equivalent to [16 mcH from
C15]. When H from 16-OH shifts to C13 in 16-HDHA,
the C15,16 allylic single bond cleaves, yielding ion m/z
233 in a -ene rearrangement. The same mechanism
occurs for O,O-d2-16-HDHA, producing ionm/z 234. On
the other hand, an -H--ene rearrangement also takes
place: the C21 Hmigrates to C17 and conjugated double
bonds 17,19 convert to 18,20 in S5c; then the C15 H
shifts to C19 and the C16,17 allylic single bond in S5c
cleaves, generating ion m/z 261 for 16-HDHA or 262 for
O,O-d2-16-HDHA (Scheme 5). Chain-plus-peripheral
ionsm/z 189 [233 CO2] (9%) of 16-HDHA and 190 [234
 CO2] (5%) of O,O-d2-16-HDHA are consistent with
the formation mechanism for ions [16 cc  H from OH
of 16-HDHA] or [16 cc  D from OD of
O,O-d2-16-HDHA].
14-HDHA and O,O-14-d2-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). Ions m/z 205 (34%) and 233
(87%) are equivalent to [14 cc  H] and [14 mc  H],
respectively, from 14-HDHA (14-hydroxy-4Z,7Z,10Z,
12E,16Z,19Z-docosahexaenoic acid). The former corre-
sponds to ion m/z 206 (68%, equivalent to [14 cc  D
from 14-OD]) in O,O-14-d2-HDHA, and the latter is
consistent with ions m/z 233 (93%, equivalent to [14 mc
 D from 14-OD]) and 234 (97%, equivalent to [14 mc
H from C13]) in O,O-14-d2-HDHA (Table 1, Supple-
mental Figure 1). Thus the H for [14 cc  H] was from
14-OH (Scheme 5); and the H for [14 mc  H] was from
both C13 and 14-OH, indicating the involvement of two
competing fragmentation mechanisms.
Ion m/z 205 forms through a -ene rearrangement
with the cleavage of the C13,14 bond and shift of 14-OH
H to C11 in S5d, which results from migration of C9 H
to C13 and conversion of conjugated double bonds
10,12 to 9,11. When C13 H in S5d shifts to C17
through an -H--ene rearrangement, the resulting ion
is at m/z 233 for 14-HDHA or 234 for O,O-d2-14-HDHA.
Meanwhile, ion m/z 233 also forms for both isotopomers
through a -ene rearrangement when 14-OH H in
14-HDHA or 14-OD D in O,O-d2-14-HDHA shifts to
C17, generating a carbonyl and breaking the C14,15
allylic single bond. The existence of carboxyl and/or
hydroxy groups in these four ions is further confirmed
by ions m/z 161 [205  CO2] (13%), 189 [233  CO2]
(7%), and 215 [233  H2O] (4%) of 14-HDHA and 162
[206  CO2] (11%), 216 [234  H2O] (5%), and 190 [234
 CO2] (15%) of O,O-d2-14-HDHA.
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Figure 1 and Scheme 5). The chain-cut ions in the
MS/MS spectrum of 13-HDHA (13-hydroxy-4Z,7Z,10Z,
14E,16Z,19Z-docosahexaenoic acid) are at m/z 193
(34%) and 221 (31%), equivalent to [13 cc  H] and [13
mc  H], respectively (Table 1, Supplemental Figure 1).
They are consistent with ions m/z 194 (50%, [13 cc  D
from 13-OD]) and 221(78%, [13 mc D from 13-OD]) in
the MS/MS spectrum of d2-13-HDHA. Therefore, H in
[13 cc  H] or [13 mc  H] is from 13-OH. These ions
correspond to the following MS/MS fragmentation
mechanisms: through a -ene rearrangement, the
13-OH H (or 13-OD D) shifts to C10, and the C12,13
allylic single bond cleaves, resulting in ion m/z 193 for
13-HDHA (194 for 13-d2-HDHA); in parallel, through a
-ene rearrangement the C13,14 vinyl single bond con-
verts to an allylic single bond in S5e when the C18 H
migrates to C14, then 13-OH H (or 13-OD D) shifts to
C16 in S5e, and the C13,14 bond breaks, generating ion
m/z 221 from both 13-HDHA and 13-d2-HDHA, equiv-
alent to [13 mc  H] and [13 mc  D], respectively.
Additionally, the chain-plus-peripheral ions m/z 203
[221  H2O] (5%) and 177 [221  CO2] (8%) of 13-
HDHA as well as ion 177 [221  CO2] (8%) of O,O-d2-
13-HDHA further confirm the composition of ion m/z
221.
11-HDHA and O,O-d2-11-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). Ions m/z 165, 177, 193, and 149
in the MS/MS spectrum of 11-HDHA (11-hydroxy-
4Z,7Z,9E,13Z,16Z,19Z-docosahexaenoic acid) are equiv-
alent to [11 cc  H], [11 cm  2H], [11 mc  H], and [11
mm], respectively. The assignments are confirmed by
ions m/z 166 [11 cc  D from 11-OD], 177 [11 cm  D
from 11-OD  H from carbon-chain], 193 [11 mc  D
from 11-OD], and 149 [11 mm] in the MS/MS spectrum
of O,O-d2-11-HDHA. These indicate the following frag-
mentation mechanisms in the MS/MS processes:
through a -ene rearrangement, the C10,11 bond in
11-HDHA changes to an allylic single bond and inter-
mediate S5f forms when C6-H shifts to C10, then 11-OH
H (or 11-OD D) shifts to C8 through a 6-membered ring
in S5f and the C10,11 allylic single bond cleaves, yield-
ing ion m/z 165 (14%) for 11-HDHA (or 166 (12%) for
O,O-d2-11-HDHA) and an aldehyde; through a -ene
rearrangement, 11-OH H in 11-HDHA or 11-OD D in
d2-11-HDHA shifts to C14, and the C11,12 allylic single
bond cleaves, generating ion m/z 193 (22% for 11-
HDHA, 21% for O,O-d2-11-HDHA) with a carbonyl
group; through an -H--ene rearrangement, the C12-H
shifts to C8 in S5f, the 11-OH H or 11-OD D migrates to
the carboxylic group, and the C11,12 bond cleaves,
yielding ion m/z 177 (8% for 11-HDHA or 7% for
d2-11-HDHA). Additionally, when 11-OH H from 11-
HDHA and 11-OD D of O,O-d2-11-HDHA shifts to the
carboxyl group, an 11-alkoxide anion (S5g) forms and
the negative charge directs the cleavage of the C11,12
allylic single bond, producing ion m/z 149 (26% for
11-HDHA, 28% for d2-11HDHA). The composition andformation mechanism for ion m/z 165 are further con-
firmed by ion 121 [165  CO2] (4%) of 11-HDHA, and
those for ion m/z 166 of d2-11-HDHA are verified by 122
[166  CO2] (4%) of d2-11-HDHA.
10-HDHA and O,O-d2-10-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). In contrast to the C10,11 bond
in 11-HDHA, the C9,10 bond in 10-HDHA (10-hydroxy-
4Z,7Z,11E,13Z,16Z,19Z-docosahexaenoic acid) is al-
ready an allylic single bond as in PD1 (Figure 2 and
Scheme 4). It cleaves through a -ene rearrangement
when 10-OHH shifts to C7 and a carbonyl group forms,
yielding ion m/z 153 (6%), which is equivalent to [10 cc
 H from 10-OH], following the same pathway as that
for ion m/z 153 from PD1 (Scheme 4), except that the
neutral loss here is a 2,4,7,10-tridecatetraenal versus the
neutral loss S4a from PD1. This is consistent with ion
m/z 154 [10 cc  D from 10-OD] (5%) in the MS/MS
spectrum of O,O-d2-10-HDHA. Ion m/z 153 in the
MS/MS spectra of the 10 series of neuroprostanes is
also likely to have been generated through this mech-
anism although their segment 10 cm is different from
that of PD1 (Figure 2 and Scheme 4 ) or 10-HDHA
[28].
In competition, a -ene rearrangement occurs along
10-OH similar to that for ion m/z 181 from PD1 (Figure
2 and Scheme 4): the migration of C15 H to C11 through
a six-membered ring converts the C10,11 vinyl bond to
an allylic single bond in S5h; then 10-OH H in 10-
HDHA or 10-OD D in O,O-d2-10-HDHA shifts to C13,
10-OH or 10-OD changes to 10-carbony, and the C10,11
single bond cleaves, generating ion m/z 181, equivalent
to [10 mc  H from 10-OH in 10-HDHA] (13%) or [10
mc  D from 10-OD of O,O-d2-10-HDHA] (37%).
8-HDHA and O,O-d2-8-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). The chain-cut ions in the
MS/MS spectrum of 8-HDHA (8-hydroxy-4Z,6E,10Z,
13Z,16Z,19Z-docosahexaenoic acid), and O,O-d2-8-
HDHA are at m/z 153 (10%, 8%), 189 (51%, 22%), and
217 (13%, 7%), which correspond to [8 mc  H/D], [8
mm], and [8 cm  HH/HD], respectively. Via a -ene
rearrangement, the migration of 8-OH H in 8-HDHA or
8-OD D of O,O-d2-8-HDHA to C11 generates 8-carbony,
dissociates the C8,9 allylic single bond, and yields ion
m/z 153, equivalent to [8 mcH from 8-OH of 8-HDHA
or D from 8-OD of O,O-d2-8-HDHA]. On the other
hand, the migration of 8-OH H of 8-HDHA or 8-OD D
of O,O-d2-8-HDHA to the carboxyl anion results in
alkoxide anion S5i, of which the negative charge directs
the cleavage of the C8,9 allylic single bond, yielding an
8-carbonyl group and ion m/z 189 [8 mm]. Ion m/z 217 is
equivalent to [8 cm  2H] for 8-HDHA or [8 cm  HD]
for d2-HDHA, generated through an -H--ene rear-
rangement: when C3 H migrates to C7 through a
six-membered ring, C7,8 becomes an allylic single bond
in S5j; in the meantime, the 8-OH H or 8-OD D shifts to
the carboxyl anion; then the C9 H in S5j shifts to C5 and
the C7,8 bond breaks, yielding ion m/z 217 in the
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ter loss of CO2, ion m/z 153 was transferred to ion m/z
109 for 8-HDHA (29%) or O,O-d2-8-HDHA (18%).
7-HDHA and O,O-d2-7-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). The chain-cut ions in the
MS/MS spectrum of 7-HDHA (7-hydroxy-4Z,8E,10Z,
13Z,16Z,19Z-docosahexaenoic acid) or O,O-d2-7-HDHA
are at m/z 141 (13%, 18%) and 201 (8%, 7%), which are
equivalent to [7 mc  H or D] and [7 mm], respectively,
and correspond to the following fragmentation mecha-
nisms. The generation of ion m/z 141 is via a -ene
rearrangement: the C12 H shifts to C8, changing the
C7,8 vinyl single bond to an allylic single bond in S5k;
then the H from 7-OH or D from 7-OD in S5k migrates
to C10 and the C7,8 bond cleaves, yielding ion m/z 141.
Competitively, the 7-OH H in S5k migrates to the
carboxyl, yielding S5l; the negative charge of the
7-alkoxide anion S5l directs the cleavage of C7,8 bond,
resulting in ion m/z 201.
4-HDHA and O,O-d2-4-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). The chain-cut ion is m/z 101
(14%) for 4-HDHA (4-hydroxy-5E,7Z,10Z,13Z,16Z,19Z-
docosahexaenoic acid) (27% for O,O-d2-4-HDHA),
which is equivalent to [4 mc  H from 4-OH of
4-HDHA or D from 4-OD of O,O-d2-4-HDHA] (Table 1,
Supplemental Figure 1). It is generated through a -ene
rearrangement: when C9 H shifts to C5, the C4,5 bond
changes to an allylic single bond (S5m); C 4,5 bond in
S5m cleaves upon the migration of 4-OH H of 4-HDHA
or 4-OD D of O,O-d2-4-HDHA to C7, generating ion m/z
101.
Identification of HDHAs from Biogenic Samples
(Figure 3)
Based on the above MS/MS spectra of HDHAs,
20-HDHA, 14-HDHA, 11-HDHA, and 10-HDHA
were found in human whole blood via LC-UV-
MS/MS detailed here as well as 17-HDHA found in
stroke-injury murine brain tissues. All the peripheral-
cut ions in these spectra match the ions in the spectra
acquired from standard compounds. There are one or
two chain-cut ions from -cleavage in these spectra
that match the ions in standard spectra (Table 1,
Supplemental Figure 1). The LC retention times and
UV spectra of each identified mono-HDHA also
match those of the corresponding standard com-
pound (data not shown). Additionally, 21,21,22,22,22-
d5-17S-HDHA (d5-17S-HDHA) was identified in the
incubation of d5-DHA with 15-LO. It has the same
position of double bonds and the position of hydroxy
as 17-HDHA, except its C21 and 22 were deuterated.
In comparison with the MS/MS spectrum of 17-
HDHA in Table 1, Supplemental Figure 1, the corre-
sponding ions shifted 5 Daltons, e.g., MS/MS ions
m/z 348 [M  H], 330 [M  H  H2O], 304 [M  H CO2], and 286 [M  H  H2O-CO2], consistent with
d5-17S-HDHA. Ions m/z 245 [17 cc  H] (27%), m/z
273 [17 mc  H] (50%), 255 [273  H2O] (7%), 229 [273
 CO2] (32%), and 201 [245  CO2] (14%) revealed
that this MS/MS spectrum is of d5-17S-HDHA. The
LC retention time and UV spectrum (max 235 nm) of
d5-17S-HDHA matched those of 17S-HDHA (data not
shown).
17-HpDHA and 21,21,22,22,22-d5-17-HpDHA
(Figure 4, Scheme 6).
There is a conjugated double bond in 17-HpDHA.
Collision-induced dissociation of the molecular ion m/z
359 [MH] from 17-HpDHA generated the peripheral-
cut ions m/z 341 [M  H  H2O], 323 [M  H  2H2O],
315 [M  H  CO2], 297 [M  H  H2O-CO2] and 279
[M  H  2H2O-CO2]. The corresponding ions in the
MS/MS spectrum of d5-17-HpDHA are 346 [M  H 
H2O], 328 [M  H  2H2O], and 320 [M  H  CO2].
Ions m/z 245 (9%) and 289 (6%) are equivalent to [17 cc
 H] and [17 mc  H] for 17-HpDHA. Ion m/z 245
forms through a-ene rearrangement: 17-hydroperoxyl
H shifts to C14 in S6a, a dioxirane ring forms on C17,
and the C16,17 bond breaks. Ion m/z 289 forms through
an -H--ene rearrangement when C16 H in S6a shifts
to C20 and the C17,18 allylic single bond breaks. Ion 289
further transfers to ions m/z 253 [289  2H2O] (5%) and
209 [289  2H2O-CO2] (4%). The presence of ions m/z
245 (36%) and 289 (23%) in the MS/MS spectrum of
d5-17-HpDHA further confirms this fragmentation
mechanisms.
Discussion
Impact of a Functional Group and Enes on MS/
MS Fragmentation of Different Lipid Mediators
Under the same MS/MS conditions as for RvD1, Lipoxin
A4 (5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic
acid) produces chain-cut ions m/z 115 [5 mc H], m/z
235 [5 mm], and m/z 251 [15 cc  H] [27, 29], equivalent
to ions m/z 141[7 mc  H], m/z 233 [7 mm], and m/z 277
[17 cc  H], respectively, from RvD1 (Figure 1, Scheme
3). This corresponds to the same structure of Lipoxin A4
between C5 and C15 as that of RvD1 between C7 and
C17, the conjugated tetraene bracketed by two vicinal
hydroxys on the carboxyl (c)-side and one hydroxy on
the methyl terminus (m)-side. However the ion m/z 279
[15 mc  H] was not observed for Lipoxin A4. There is
no double bond at  position to 15-OH on the m side
of Lipoxin A4, i.e., in segment 15 mm, to facilitate
generation of this ion through an -H--ene rearrange-
ment that yields ion [17 mc  H] m/z 305 from RvD1.
The same phenomenon was observed for 15-hydroxy-
eicosatetraenoic acid (15-HETE) versus 17-HDHA and
PD1. 15-HETE has no [15 mc  H] ion (m/z 247), but
17-HDHA and PD1 have [17 mc  H] ions as m/z 273
and 289, respectively. Therefore, ion [x mc  H] indi-
pray
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senting the position of the functional group.
7-HDHA also has the same chain-cut ions as RvD1
does: [7 mc  H] and [7 mm] around 7-OH (Figure 1,
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single bond. The [7 mm] ions m/z 233 and 201 are
generated through the same mechanism from RvD1 and
7-HDHA, respectively. Analogously, 5-HETE has the
chain-cut ions m/z 115 ([5 mc  H]) and 203 ([5 mm])
around 5-OH; this is similar to what LXA4 has [27, 29, 30].
Although there is an 8-OH in both RvD1 and
8-HDHA, there are no MS/MS ions from RvD1 analo-
gous to ions [8 cm  2H], [8 mc  H], and [8 mm] from
8-HDHA (Figure 1, Table 1, Supplemental Figure 1, and
Schemes 3 and 5). Because of the 7-OH and the conju-
gated tetraene 9,11,13,15 of RvD1, the 8 cm (equal to 7
mm) segment of RvD1 is involved in formation of ion
m/z 233 as 7 mm, not as 8 cm, namely, it follows the
fragmentation mechanism to produce ion [7 mm] in-
stead of [8 cm  2H]. The ion m/z 141, coming from
segment 8 cc (equivalent to 7 mc) of RvD1, is equivalent
to [7 mcH] instead of [8 ccH]. RvD1 has the [8 mm
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[cc  H] ions are generated with the shift of H from the
hydroxy or hydroperoxy to the  position in segment cc
through a -ene rearrangement if the segment cc has a
 double bond, an  vinyl single bond, and an allylic
hydrogen (for 20-HDHA and 17-HDHA) or conjugated-
triene (for 17 cc in RvD1 and PD1, 12 cc of LTB4 [19], 15
cc of LXA4 [19] that can facilitate the migration of 
electrons from the  double bond to the -bond and
convert the  vinyl single bond to an  allylic single
bond. Examples are ions m/z 277 from RvD1 (Figure 1
and Scheme 3), 261 from PD1 (Figure 2, Scheme 4), 245
from 17-HpDHA (Figure 4 and Scheme 6), 195 from
LTB4 and 251 from LXA4 [27, 29], as well as ions 285
from 20-HDHA, 245 from 17-HDHA, 205 from 14-
HDHA, and 165 from 11-HDHA (Table 1, Supplemental
Figure 1 and Scheme 5). These fragmentation processes
can also occur through -ene-rearrangement if the cc
segment has a  double bond, which is at least the
second double bond counted from the carboxyl group
(for ion-trap MS/MS, unnecessary for triple-
quadrupole MS/MS, such as for 8 cc of 8,9-dihydroxy-
eicosatrienoic acids [27], and an  allylic single bond
(Schemes 3 to 6). Examples are ions m/z 153 from PD1
(Figure 2, Scheme 4), as well as 153 from 10-HDHA, 233
from 16-HDHA, and 193 from 13-HDHA (Table 1,
Supplemental Figure 1 and Scheme 5). Additional ex-
amples are ions m/z 167 from 11,12-diHETrE (dihydroxy
eicosatrienoic acid), 207 from 14,15-diHETrE, 195 from
5,12-diHETE (dihydroxyeicosatetraenoic acid), 235 from
5,15-dihydroxy-eicosatetraenoic acid, and 221 from li-
poxin B4 [27, 29].
There is no double bond in 4 cc of 4-HDHA and no
allylic hydrogen that can facilitate the migration of the
 electrons of the  double bond to the -bond in 8 cc of
8-HDHA. The double bond in 7 cc of 7-HDHA and
RvD1 is the first double bond counted from the car-
boxyl group. Therefore these hydroxys have no [ccH]
ions (for ion-trap mass spectrometer LCQ, ThermoElec-
tron).
[mc  H] Ions in MS/MS of Lipid Mediators
[mcH] ions are generated with shift of the hydroxy H
to the  position in segment mm, through a -ene
rearrangement if the mm has a  double bond, an 
vinyl single bond, and an allylic hydrogen (for 13-
HDHA, 10-HDHA, 7-HDHA, and 4-HDHA in Scheme
5) or conjugated-triene (for 10 mm in PD1) that can
facilitate the migration of  electrons of the  double
bond to the -bond and convert the  vinyl single bond
to an  allylic single bond. Examples include ions m/z
221 from 13-HDHA, 181 from 10-HDHA, 141 from
7-HDHA, and 101 from 4-HDHA (Table 1, Supplemen-
tal Figure 1 and Scheme 5), as well as ion m/z 181 from
PD1 (Figure 2, Scheme 4). This process also takes place
through -ene-rearrangement if the segment mm has a
-double bond and an  allylic single bond. Examplesare ions 141 from RvD1 (Figure 1, Scheme 3), 193 from
11-HDHA, and 153 from 8-HDHA (Table 1, Supplemen-
tal Figure 1 and Scheme 5), as well as ions 145 of
5,6-diHETrE, 185 of 8,9-diHETrE, and 115 of both
5,6-diHETE and LXA4 [27, 29, 30]. [mc  H] ions are
also produced through an -H--ene rearrangement
with shift of the -H from segment mc to the  position
in segment mm whose -bond is a vinyl single bond
and -bond is a double bond, such as ions m/z 261 from
16-HDHA (Table 1, Supplemental Figure 1 and Scheme
5), m/z 305 from RvD1 (Figure 1, Scheme 3), m/z 289
from PD1 (Figure 2, Scheme 4), m/z 233 from 14-HDHA,
273 from 17-HDHA (Table 1, Supplemental Figure 1
and Scheme 5), and m/z 289 from 17-HpDHA (Figure 4,
Scheme 6).
[cm  2H] and [mm] Ions in MS/MS
of Lipid Mediators
Only three [cm  2H] ions were observed: m/z 205 from
PD1 (Figure 2, Scheme 4), m/z 177 from 11-HDHA and
m/z 217 from 8-HDHA (Table 1, Supplemental Figure 1
and Scheme 5), which are generated through a -ene
rearrangement and an -H--ene rearrangement, re-
spectively. For PD1, the 17-OH H was extracted from
cm to cc by the carboxyl group and 10-OH H was
extracted to C7 of the cc. For 11-HDHA and 8-HDHA,
the -H is in segment cm and is extracted to segment cc
that has a -ene (the  electrons come from the -ene of
the molecular ion); the OH H is extracted from cm to cc
by the carboxyl group. The [mm] ions detected are m/z
233 ([7 mm]) from RvD1 (Figure 1, Scheme 3), as well as
ions m/z 149 ([11 mm]) from 11-HDHA, 189 ([8 mm])
from 8-HDHA, and 201 ([7 mm]) from 7-HDHA (Table
1, Supplemental Figure 1 and Scheme 5). They are
generated through charge-direct fragmentation mecha-
nisms, where the negative charge of the transient alkox-
ide anion, resulted from extraction of the hydroxy H by
the carboxylic group, directing the cleavage of the 
allylic single bond in mm.
Conclusions
ESI-MS/MS analysis of underivatized ESI-deprotonated
molecules of resolvin D1, protectin D1, and other DHA-
derived products reveals the structures, especially the
locations of hydroxy, hydroperoxy, or carbonyl groups, as
well as the double bonds. The definitive fingerprints are
the CID MS/MS ions formed via cleavage of the carbon
chain, namely chain-cut ions. These ions are generated via
charge-remote and/or charge-directed fragmentation
mechanisms as depicted in Schemes 2 to 6. The CID
fragmentation usually consists of several serial and paral-
lel reactions. Each chain-cut ion is equivalent to the
corresponding hypothetically homolytic segment (cc, cm,
mc, or mm) with addition or extraction of up to two
protons. Deuterium labeling facilitated the structural anal-
ysis of MS/MS ions and the corresponding fragmentation
144 HONG ET AL. J Am Soc Mass Spectrom 2007, 18, 128–144mechanisms. The molecular ion structures determine the
fragmentation mechanisms, which in turn provide the
rationale for the assignment of the MS/MS ion structures,
and consequently the molecular ion structures of the
DHA-derived compounds. This paper demonstrates a
simple approach for comprehensive structure analysis of
DHA-derived products without the need for derivatizing
the compounds. The fragmentation rules reported here
were used for the development of a database and search
algorithm for the theoretic MS/MS spectra of novel com-
pounds derived from fatty acids [23].
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